Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.PRNewsWire • 08/30/24
Novavax Reports Second Quarter 2024 Financial Results and Operational HighlightsPRNewsWire • 08/08/24
Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024PRNewsWire • 08/01/24
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?Investors Business Daily • 07/19/24
Wall Street Bulls Look Optimistic About Novavax (NVAX): Should You Buy?Zacks Investment Research • 07/15/24
Meme Stock or Vaccine Stock? Novavax's Identity Crisis and Why It Matters for InvestorsInvestorPlace • 06/28/24